Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
EMEA Revenue	692.77M	690.34M	667.83M
APAC Revenue	101.03M	101.48M	96.24M
North America Revenue	321.83M	362.06M	308.95M
South America Revenue	29.47M	32.40M	31.02M
Revenue (Other)	5.00K	-	1,000.00
Revenue (Total)	1.15B	1.19B	1.10B

Revenue

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biopharmaceutical and Diagnostic Solutions Revenue	976.82M	1.04B	933.74M
Engineering Revenue	168.28M	148.11M	170.29M
Revenue (Other)	4.00K	-	-
Revenue (Total)	1.15B	1.19B	1.10B

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biopharmaceutical and Diagnostic Solutions Gross Profit	298.47M	328.15M	268.78M
Engineering Gross Profit	47.14M	31.02M	56.17M
Eliminations from Gross Profit	-24.54M	-15.29M	-22.63M
Gross Profit (Other)	46.00K	-	-
Gross Profit (Total)	321.12M	343.88M	302.32M

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biopharmaceutical and Diagnostic Solutions Operating Profit	193.51M	220.43M	165.64M
Engineering Operating Profit	28.95M	9.33M	33.10M
Eliminations from Operating Profit	-38.58M	-30.95M	-37.59M
Operating Income (Other)	-57.00K	-	-
Operating Income (Total)	183.82M	198.80M	161.14M

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Backlog	871.00M	853.00M